Stay updated with breaking news from Clinical Decision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced an
Washington lawmakers and regulators are delving into the complexities of regulating AI's use in the healthcare sector.
More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.
Ultimately, to get generative AI in healthcare right we need input from the clinicians who will use these tools – and who understand the ramifications of applying AI without first rigorously testing applications to ensure they are safe and provide clear clinical value.
The capabilities and sophistication of digital health technologies are constantly expanding, especially with the integration of artificial intelligence and machine learning.